Predictive Value of Circulatory Total VEGF-A and VEGF-A Isoforms for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small-Cell Lung Cancer

20252 citationsJournal Articlegold Open Access

Authors

Serum VEGF<sub>121</sub> levels may be useful in predicting anti-PD-1/PD-L1 antibody monotherapy efficacy.

Published in: Cancers

Volume 17, Issue 4, pp. 572-572

Field-Weighted Citation Impact: 2.09